Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19

dc.contributor.authorGarcía Ríos, Estéfani
dc.contributor.authorLeivas, Alejandra
dc.contributor.authorMancebo, Francisco J.
dc.contributor.authorSánchez Vega, Laura
dc.contributor.authorLanzarot, Diego
dc.contributor.authorAguado García, José María
dc.contributor.authorMartínez López, Joaquín
dc.contributor.authorPaciello, María Liz
dc.contributor.authorPérez Romero, Pilar
dc.date.accessioned2023-06-22T10:45:42Z
dc.date.available2023-06-22T10:45:42Z
dc.date.issued2022-03-09
dc.description.abstractIn order to demonstrate the feasibility of preparing clinical-grade SARS-CoV-2-specific T-cells from convalescent donors and the ability of these cells to neutralize the virus in vitro, we used blood collected from two COVID-19 convalescent donors (before and after vaccination) that was stimulated with specific SARS-CoV-2 peptides followed by automated T-cell isolation using the CliniMacs Prodigy medical device. To determine cytotoxic activity, HEK 293T cells were transfected to express the SARS-CoV-2 M protein, mimicking SARS-CoV-2 infection. We were able to quickly and efficiently isolate SARS-CoV-2-specific T lymphocytes from both donors before and after they received the Pfizer-BioNTech vaccine. Althoughbefore vaccination, the final product contained up to 7.42% and 30.19% of IFN-γ+ CD3+ T-cells from donor 1 and donor 2, respectively, we observed an enrichment of the IFN-γ+ CD3+ T-cells after vaccination, reaching 70.47% and 42.59%, respectively. At pre-vaccination, the isolated SARS-CoV-2-specific T-cells exhibited cytotoxic activity that was significantly higher than that of unstimulated controls (donor 2: 15.41%, p-value 3.27 × 10−3). The cytotoxic activity of the isolated SARS-CoV-2-specific T-cells also significantly increased after vaccination (donor 1: 32.71%, p-value 1.44 × 10−5; donor 2: 33.38%, p-value 3.13 × 10−6). In conclusion, we demonstrated that SARS-CoV-2-specific T-cells can quickly and efficiently be stimulated from the blood of convalescent donors using SARS-CoV-2-specific peptides followed by automated isolation. Vaccinated convalescent donors have a higher percentage of SARS-CoV-2-specific T-cells and may be more suitable as donors. Although further studies are needed to assess the clinical utility of the functional isolated SARS-CoV-2-specific T-cells in patients, previous studies using the same stimulation and isolation methods applied to other pathologies support this idea.en
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (España)/Fondo Europeo de Desarrollo Regional
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipUniversidad Complutense de Madrid/Comunidad de Madrid
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/72840
dc.identifier.citationGarcía Ríos, E., Laivas, A., Mancebo, F. J. et al. «Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19». Biomedicines, vol. 10, n.o 3, marzo de 2022, p. 630. DOI.org (Crossref), https://doi.org/10.3390/biomedicines10030630.
dc.identifier.doi10.3390/biomedicines10030630
dc.identifier.issn2227-9059
dc.identifier.officialurlhttps://doi.org/10.3390/biomedicines10030630
dc.identifier.relatedurlhttps://www.mdpi.com/2227-9059/10/3/630/htm
dc.identifier.urihttps://hdl.handle.net/20.500.14352/71610
dc.issue.number3
dc.journal.titleBiomedicines
dc.language.isoeng
dc.page.initial630
dc.publisherMPDI
dc.relation.projectID(REIPI RD16/0016)
dc.relation.projectID(COVID-19 Research Call COV20/00181); (F18III/00013); (CD18CIII/00007)
dc.relation.projectIDREACT-EU
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.keywordSARS-CoV-2
dc.subject.keywordT-lymphocytes
dc.subject.keywordCytotoxicity
dc.subject.keywordM protein
dc.subject.ucmInmunología
dc.subject.unesco2412 Inmunología
dc.titleIsolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19en
dc.typejournal article
dc.volume.number10
dspace.entity.typePublication
relation.isAuthorOfPublication6f2765d7-77be-4ef3-98a1-3d16f6d8510a
relation.isAuthorOfPublication5d58b324-f60e-4598-941b-4a07291634a9
relation.isAuthorOfPublication.latestForDiscovery6f2765d7-77be-4ef3-98a1-3d16f6d8510a

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
biomedicines-10-00630.pdf
Size:
1.54 MB
Format:
Adobe Portable Document Format

Collections